ScreenerHero

IANiAnthus Capital Holdings, Inc.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · ianthus.com
0.0050CAD0.00%Mkt Cap: 25.40M $P/E: —

iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. The company also develops, produces, and distributors of branded cannabis produc…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$62.66BUSDP/E 24.3
TAK
Takeda Pharmaceutical Company Limited
$60.33BUSD
TEVA
Teva Pharmaceutical Industries Limited
$46.72BUSDP/E 66.8
HLN
Haleon plc
$41.16BUSDP/E 19.5
ZTS
Zoetis Inc.
$29.48BUSDP/E 11.6
ZOE
Zoetis Inc.
$27.77BUSDP/E 11.6
UTHR
United Therapeutics Corporation
$21.22BUSDP/E 17.7
VTRS
Viatris, Inc.
$19.47BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.80BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.63BUSDP/E 21.0
IPN
Ipsen S.A.
$13.27BUSDP/E 24.0
ELAN
Elanco Animal Health Incorporated
$11.20BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.33BUSDP/E 30.2
KRK
Krka, d. d.
$8.66BUSDP/E 18.8
ALKS
Alkermes plc
$7.41BUSDP/E 116.3
AMRX
Amneal Pharmaceuticals, Inc.
$7.02BUSDP/E 42.0
HIMS
Hims & Hers Health, Inc.
$6.85BUSD
LNTH
Lantheus Holdings, Inc.
$6.55BUSDP/E 24.0
KNSA
Kiniksa Pharmaceuticals International, plc
$6.10BUSDP/E 78.9
LQDA
Liquidia Corporation
$5.95BUSDP/E 47.5

Key Statistics

Company
Market Cap25.40M $
Enterprise Value193.65M $
Revenue (TTM)101.33M $
Gross Profit47.84M $
Net Income (TTM)-29.28M $
Revenue/Share0.0153 USD
Last Price0.0050 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees690
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA45074T1021
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA40.71
EV/Revenue1.91
P/S0.25
P/B-0.19
EPS (TTM)-0.01
EPS (Forward)0.00
52W Range
0.00500% of range0.0150
52W High0.0150 CAD
52W Low0.0050 CAD
Profitability
Gross Margin45.63%
Oper. Margin-4.53%
EBITDA Margin4.70%
Profit Margin-27.92%
ROE39.02%
ROA-15.71%
Growth
Revenue Growth0.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.29M $
CapEx (TTM)17.41M $
FCF Margin-10.29%
FCF Yield-41.04%
Net Debt168.25M $
Net Debt/EBITDA35.37
Balance Sheet
Debt/Equity-2.21
Current Ratio0.17
Quick Ratio0.05
Book Value/Sh-0.0266 CAD
Cash/Share0.0010 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.6.97B
Float1.42B
Insiders4.61%
Institutions76.30%
Short Interest
Short Ratio0.9d
Short % Float0.00%
Short % Out.0.00%
Shares Short30
Short (prev mo.)30
Technical
SMA 500.0055 (-9.1%)
SMA 2000.0056 (-11.1%)
Beta-0.72
S&P 52W Chg14.29%
Avg Vol (30d)149.37K
Avg Vol (10d)24.79K
Technical Indicators
RSI (14)47.8
MACD-0.0001
MACD Signal-0.0002
MACD Hist.+0.0000
BB Upper0.0050 CAD
BB Middle0.0050 CAD
BB Lower0.0050 CAD
BB Width0.00%
ATR (14)0.0005 CAD
Vol Ratio (20d)0.65x